DAVID W. GRYSKA - 19 Apr 2022 Form 4 Insider Report for Seagen Inc.

Role
Director
Signature
By: /s/ Jennifer Prosba For: David W. Gryska
Issuer symbol
N/A
Transactions as of
19 Apr 2022
Net transactions value
-$495,543
Form type
4
Filing time
21 Apr 2022, 18:37:01 UTC
Previous filing
09 Feb 2022
Next filing
17 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Options Exercise $35,988 +1,794 +3.9% $20.06* 48,044 19 Apr 2022 Direct F1
transaction SGEN Common Stock Sale $257,116 -1,794 -3.7% $143.32 46,250 19 Apr 2022 Direct F1, F2, F3
transaction SGEN Common Stock Options Exercise $30,411 +1,516 +3.3% $20.06* 47,766 19 Apr 2022 Direct F1
transaction SGEN Common Stock Sale $218,562 -1,516 -3.2% $144.17 46,250 19 Apr 2022 Direct F1, F2, F4
transaction SGEN Common Stock Options Exercise $13,841 +690 +1.5% $20.06* 46,940 19 Apr 2022 Direct F1
transaction SGEN Common Stock Sale $100,105 -690 -1.5% $145.08 46,250 19 Apr 2022 Direct F1, F2, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,794 -45% $0.000000 2,206 19 Apr 2022 Common Stock 1,794 $20.06 Direct F6
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,516 -69% $0.000000 690 19 Apr 2022 Common Stock 1,516 $20.06 Direct F6
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -690 -100% $0.000000* 0 19 Apr 2022 Common Stock 690 $20.06 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 Reflects sales of common stock executed in multiple transactions at prices ranging from $142.84 to $143.82. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F4 Reflects sales of common stock executed in multiple transactions at prices ranging from $143.84 to $144.83. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F5 Reflects sales of common stock executed in multiple transactions at prices ranging from $144.91 to $145.40. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F6 Options were fully vested on 5/17/13.